Step 1 General Pathology

General Pathology is the mechanistic backbone of USMLE Step 1 — it explains why disease happens, not just what disease looks like. It spans cell injury and death, inflammation and repair, and the full arc of neoplasia from oncogene activation to metastasis and paraneoplastic syndromes. Questions here reward students who understand the underlying cascade, not just the endpoint. For anyone studying high-yield pathology for Step 1, cell injury mechanisms and neoplasia genetics are the two foundations that support every organ-system block.

Testing style is mixed but leans heavily clinical. Cell injury questions often present an ischemia vignette and ask what happens at a specific timepoint. Inflammation questions embed mediator pharmacology into drug mechanism questions. Neoplasia integrates heavily with genetics — expect a family history vignette requiring you to apply Knudson's two-hit model or identify a specific chromosomal translocation. Students consistently get the Rb phosphorylation state backwards: phosphorylated Rb releases E2F and permits cell-cycle progression, so phosphorylated Rb is the pro-growth state, not the tumor-suppressing state.

The tricky part of USMLE general pathology is precision. Apoptosis versus necrosis, dystrophic versus metastatic calcification, grading versus staging — the distinctions feel minor until the answer choices force you to commit. Another common misconception: students confuse dystrophic and metastatic calcification by assuming calcium levels determine the type, when dystrophic calcification occurs in damaged tissue with entirely normal serum calcium. High-yield pitfalls also cluster around Bcl-2 function, which necrosis type applies to which organ, and which lung cancer subtype drives which paraneoplastic syndrome. Learn the logic behind each rule and the exceptions stop being surprises.